Pharmaceutical Company manufactures one of the most widely used diabetes medicines in the United States and Asia. Recently, the Food and Drug Administration has received an increased number of complaints from consumers about the extensive longterm side effects they have started to experience as a result of the drug. After reevaluating the drug, the FDA determined that it is no longer considered safe and has banned its sale in the United States. Because the authority of the FDA extends only to sales in the United States, Pharmaceutical Company remains able to continue selling the drug in Asia. Applying ethical principles, decide whether the company should continue to do so. How, if at all, would your answer be affected by learning that Pharmaceutical Company has been the only drug manufacturer willing to sell a diabetes drug in Asia at a discounted price that enables low-income individuals to afford medication to help manage their disease?